Robo1-Fc fusion protein and use thereof for treating tumours
US9493529B2 · kind B2 · utility
17Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2011 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Apr 8, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a Robo1-Fc recombinant protein and to the use thereof for treating diseases in which a Slit protein is overexpressed, in particular cancer. The invention also relates to a composition including such a recombinant protein. Another aspect of the invention involves using a Robo1-Fc molecule as a diagnostic tool for detecting the overexpression of a molecule belonging to the Slit family in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.